Pharmacists play a vital role in supporting multiple sclerosis patients by addressing medication challenges, educating on treatments, and navigating insurance hurdles.

Experts say SMS-based engagement tools can help pharmacists improve medication adherence and reduce hospital readmissions by addressing common patient barriers such as forgetfulness and cost.

Explore how pharmacists enhance access to care for multiple sclerosis patients, tackling barriers in diagnosis, treatment, and patient education.

GLP-1 receptor agonist effectiveness and tolerability can be significantly improved through targeted pharmacist counseling on alcohol reduction.

Pharmacists play a crucial role in educating multiple sclerosis patients about treatment options, side effects, and navigating insurance challenges.

Reducing alcohol intake alongside GLP-1 therapy may significantly improve outcomes for patients with obesity or diabetes risk.

Ben Long, MD, and Weston Blakeslee, PhD, discuss how pharmacists can integrate automated SMS tools to reduce readmissions while minimizing workflow burden.

Ann Marie Navar, MD, PhD, explains how enlicitide decanoate delivers LDL-C reductions comparable with injectable PCSK9 inhibitors, which could improve access to nonstatin therapy for patients not at goal.

Jordan Harper, DMD, discusses innovative fluoride-free toothpaste tablets with hydroxyapatite, offering effective oral care solutions for all patients.